C12N 2760/10051
Methods of production or purification of viral material
C12N2760/10051 (Methods of production or purification of viral material) appears on 8 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 14
- Assignees
- 9
- Inventors
- 53
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 3 |
| 2023 | 0 | 1 |
| 2024 | 2 | 0 |
| 2025 | 0 | 4 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Virus particles for therapeutic purposes18 Aug 2026US 12,708,654 B2Abalos Therapeutics GmbH
- Method for producing an antitumoral arenavirus as well as arenavirus mutants29 Oct 2024US 12,129,281 B2Abalos Therapeutics GmbH
- Lassa vaccine7 May 2024US 11,976,305 B2Centre National De La Recherche Scientifique
- HPV vaccines9 Aug 2022US 11,407,790 B2Hookipa Biotech GmbH
- Modified arenavirus1 Mar 2022US 11,260,090 B2University of Vermont and State Agricultural College
- Multivalent vaccines against tuberculosis30 Jul 2026US 2026/0218232 A1Regents of the University of Minnesota
- Multivalent mopevac-based immunogenic composition for vaccination against new world arenaviruses and therapeutic use(s) thereof3 Jul 2025US 2025/0213670 A1
- Method for producing an antitumoral arenavirus as well as arenavirus mutants17 Apr 2025US 2025/0122244 A1Abalos Therapeutics GmbH
- Viral vectored vaccines for swine influenza virus and methods of use13 Mar 2025US 2025/0082743 A1
- Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associated antigen as cancer immunotherapies6 Mar 2025US 2025/0073324 A1Hookipa Biotech GmbH
Most cited
By later US patents
- HPV vaccines6US 10,669,315 B2Hookipa Biotech GmbH · 2020
- Method of producing vaccines6US 4,071,619 A1978
- Pathogen restriction factors2US 8,993,318 B2The Brigham and Women S Hospital, Inc. · 2015
- HPV vaccines1US 11,407,790 B2Hookipa Biotech GmbH · 2022
- Method for producing an antitumoral arenavirus as well as arenavirus mutants1US 12,129,281 B2Abalos Therapeutics GmbH · 2024